Skip to content
    GV (Google Ventures) logo

    GV (Google Ventures)

    San Francisco, California, United StatesFounded 2009

    Launched as Google Ventures in 2009, GV is the venture capital investment arm of Alphabet, Inc. and operates as a non-strategic, financially-driven venture firm with Alphabet as its sole limited partner. With over $13 billion in assets under management, GV invests from seed to growth stages across technology and life sciences sectors, supporting over 400 active portfolio companies across North America, Europe, and Israel.

    Average disclosed round size is $113.5M (across 1074 rounds with reported amounts).

    Find people at GV (Google Ventures) on Goldilocks AI

    Portfolio

    689

    Fund Size

    $13B

    Top Stage

    Series A

    Last 12 Mo

    61

    Team

    Dave Munichiello

    Dave Munichiello

    Managing Partner

    David Krane

    David Krane

    CEO & Managing Partner

    Krishna Yeshwant

    Krishna Yeshwant

    Managing Partner

    Tom Hulme

    Tom Hulme

    Managing Partner

    Anthony Philippakis

    Anthony Philippakis

    General Partner

    Ben Robbins

    Ben Robbins

    General Partner

    Brendan Bulik-Sullivan

    Brendan Bulik-Sullivan

    General Partner

    Crystal Huang

    Crystal Huang

    General Partner

    David Schenkein

    David Schenkein

    General Partner

    Erik Nordlander

    Erik Nordlander

    General Partner

    Frédérique Dame

    Frédérique Dame

    General Partner

    Issi Rozen

    Issi Rozen

    General Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    1253 investments
    CompanyRoundAmountDate
    Treeline Biosciences logoTreeline BiosciencesSeries A$200MSep 2026
    UJET logoUJETSeries D$76MSep 2026
    Encoded Therapeutics logoEncoded TherapeuticsSeries F$275MSep 2026
    Merida Biosciences logoMerida BiosciencesSeries A$121MAug 2026
    Blacksmith logoBlacksmithSeries B$45MAug 2026
    LLifeMineSeries E$188MAug 2026
    Obsidian Security logoObsidian SecuritySeries D$85MAug 2026
    Wonder logoWonderSeries D$650MJul 2026
    Nebex logoNebexSeed$30MJun 2026
    Oblenio Bio logoOblenio BioSeries B$62MJun 2026
    Oblenio Bio logoOblenio BioSeries A—Jun 2026
    Signos logoSignosUnknown$20MMay 2026
    Rani Therapeutics logoRani TherapeuticsSeries A$39MMay 2026
    RRecursive SuperintelligenceSeries A$500MMay 2026
    RRecursive SuperintelligenceSeed$650MMay 2026
    Sierra logoSierraSeries E$950MMay 2026
    Stipple Bio logoStipple BioSeries A$100MApr 2026
    Censys logoCensysSeries D$70MMar 2026
    Sift logoSiftSeries B$42MMar 2026
    Mestag Therapeutics Limited logoMestag Therapeutics LimitedSeries B$40MMar 2026
    Guild.ai logoGuild.aiSeed$14MMar 2026
    Basis logoBasisSeries A$100MFeb 2026
    Apptronik logoApptronikSeries A$935MFeb 2026
    Apptronik logoApptronikGrowth—Feb 2026
    Inertia logoInertiaSeries A—Feb 2026
    Page 1 of 51

    Top Co-Investors

    Last updated: 27 September 2026